|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Prepaid expenses and other current assets | |||||||
| Total Current Assets | |||||||
| Investments held in Trust Account | |||||||
| Total Assets | |||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
| Current Liabilities | |||||||
| Accrued expenses | |||||||
| Income tax payable | |||||||
| Promissory Note, Sponsor | |||||||
| Accrued offering costs | |||||||
| Total Current Liabilities | |||||||
| Warrant liability | |||||||
| Deferred underwriting fee payable | |||||||
| Total Liabilities | |||||||
| Class A common stock, $0.0001 par value; subject to possible redemption, 23,817,701 shares at $10.03 and $10.00 per share of redemption value as of September 30, 2022 and December 31, 2021, respectively | |||||||
| Stockholders' Deficit | |||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2022 and December 31, 2021 | |||||||
| Common Stock | |||||||
| Common Class A [member] | |||||||
| Common Class B [member] | |||||||
| Additional paid in capital | |||||||
| Accumulated deficit | |||||||
| Common Class A [member] | |||||||
| Common Class B [member] | |||||||
| Total Stockholders' Deficit | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...